Identification
- Composition (DCI)
- rasburicase
- Manufacturer
- SANOFI AVENTIS MAROC
- ATC code
- V03AF07
- Presentation
- Boite de 3 flacons et de 3 ampoules
- Schedule / Reimb.
- A
- Hospital price
- 1431.00 MAD
Indications
Traitement et prophylaxie de l’hyperuricémie aiguë, en vue de prévenir l’insuffisance rénale aiguë, chez les adultes, enfants et adolescents (âgés de 0 à 17 ans) souffrant d’une hémopathie maligne avec masse tumorale élevée et ayant un risque de réduction ou de lyse tumorale rapide lors de l’initiation de la chimiothérapie.
Find an open pharmacy
On-call pharmacies near you
About FASTURTEC 1.5 MG / ML
FASTURTEC 1.5 MG / ML is marketed in Morocco by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of FASTURTEC 1.5 MG / ML, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about FASTURTEC 1.5 MG / ML
Answers to common questions from Moroccan patients about this drug.